Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis

Abstract

Abstract Recent studies have demonstrated significant molecular parallels between atopic dermatitis and alopecia areata as predominantly TH2‐mediated diseases. This case report highlights the potential for Dupilumab as a targeted biologic therapy in both atopic dermatitis and alopecia areata.